Template:Presumed GC chlamydia of pharynx - Revision history

Zbuchwald: /* Presumed GC/chlamydia of the pharynx (uncomplicated)Cyr SS et al. Update to CDC’s Treatment Guidelines for Gonococcal Infection, 2020. MMWR. Center for Disease Control and Prevention. 2020. 69(50):1911-1916 */

2024-09-22T02:51:49Z

Presumed GC/chlamydia of the pharynx (uncomplicated)Cyr SS et al. Update to CDC’s Treatment Guidelines for Gonococcal Infection, 2020. MMWR. Center for Disease Control and Prevention. 2020. 69(50):1911-1916

← Older revision		Revision as of 02:51, 22 September 2024
Line 16:		Line 16:
	**For persons with a history of a beta-lactam allergy, a thorough assessment of the reaction is recommended.<ref>CDC. Sexually transmitted diseases treatment guidelines. MMWR Recomm Rep 2015;64(No. RR-3). https://www.cdc.gov/mmwr/preview/mmwrhtml/rr6403a1.htm.</ref>		**For persons with a history of a beta-lactam allergy, a thorough assessment of the reaction is recommended.<ref>CDC. Sexually transmitted diseases treatment guidelines. MMWR Recomm Rep 2015;64(No. RR-3). https://www.cdc.gov/mmwr/preview/mmwrhtml/rr6403a1.htm.</ref>
	**For persons with an anaphylactic or other severe reaction (e.g. [[Stevens Johnson syndrome]]) to ceftriaxone, consult an infectious disease specialist for an alternative treatment recommendation.		**For persons with an anaphylactic or other severe reaction (e.g. [[Stevens Johnson syndrome]]) to ceftriaxone, consult an infectious disease specialist for an alternative treatment recommendation.

			<br>
			<u>Test of Cure</u><br>
			CDC recommends a repeat culture be obtained 7-14 days after initial treatment only in persons with pharyngeal gonorrhea.

Rossdonaldson1: /* Presumed GC/chlamydia of the pharynx (uncomplicated):Cyr SS et al. Update to CDC’s Treatment Guidelines for Gonococcal Infection, 2020. MMWR. Center for Disease Control and Prevention. 2020. 69(50):1911-1916 */

2020-12-23T18:42:06Z

Presumed GC/chlamydia of the pharynx (uncomplicated):Cyr SS et al. Update to CDC’s Treatment Guidelines for Gonococcal Infection, 2020. MMWR. Center for Disease Control and Prevention. 2020. 69(50):1911-1916

← Older revision		Revision as of 18:42, 23 December 2020
Line 1:		Line 1:
	===Presumed [[GC]]/[[chlamydia]] of the pharynx (uncomplicated):<ref>Cyr SS et al. Update to CDC’s Treatment Guidelines for Gonococcal Infection, 2020. MMWR. Center for Disease Control and Prevention. 2020. 69(50):1911-1916</ref>===		===Presumed [[GC]]/[[chlamydia]] of the pharynx (uncomplicated)<ref>Cyr SS et al. Update to CDC’s Treatment Guidelines for Gonococcal Infection, 2020. MMWR. Center for Disease Control and Prevention. 2020. 69(50):1911-1916</ref>===
	<u>Standard</u><br>		<u>Standard</u><br>
	''Typically, treatment for '''both''' gonorrhea and chlamydia is indicated, if one entity is suspected.''<br>		''Typically, treatment for '''both''' gonorrhea and chlamydia is indicated, if one entity is suspected.''<br>

Rossdonaldson1: Created page with "===Presumed GC/chlamydia of the pharynx (uncomplicated):Cyr SS et al. Update to CDC’s Treatment Guidelines for Gonococcal Infection, 2020. MMWR. Center for Dise..."

2020-12-23T18:40:28Z

Created page with "===Presumed GC/chlamydia of the pharynx (uncomplicated):<ref>Cyr SS et al. Update to CDC’s Treatment Guidelines for Gonococcal Infection, 2020. MMWR. Center for Dise..."

New page

===Presumed [[GC]]/[[chlamydia]] of the pharynx (uncomplicated):<ref>Cyr SS et al. Update to CDC’s Treatment Guidelines for Gonococcal Infection, 2020. MMWR. Center for Disease Control and Prevention. 2020. 69(50):1911-1916</ref>===
Standard 
''Typically, treatment for '''both''' gonorrhea and chlamydia is indicated, if one entity is suspected.'' 
 
*Gonorrhea
**[[Ceftriaxone]] IM x 1
***500 mg, if weight <150 kg
***1 g, if weight ≥150 kg
*Chlamydia
**Nonpregnant: [[doxycycline]] 100 mg PO BID x 7 days
**Pregnant: [[azithromycin]] 1 g PO x 1

 
Ceftriaxone contraindicated 
*No reliable alternative treatments are available for pharyngeal gonorrhea
**For persons with a history of a beta-lactam allergy, a thorough assessment of the reaction is recommended.<ref>CDC. Sexually transmitted diseases treatment guidelines. MMWR Recomm Rep 2015;64(No. RR-3). https://www.cdc.gov/mmwr/preview/mmwrhtml/rr6403a1.htm.</ref>
**For persons with an anaphylactic or other severe reaction (e.g. [[Stevens Johnson syndrome]]) to ceftriaxone, consult an infectious disease specialist for an alternative treatment recommendation.